Microdosing semaglutide helps lose weight more slowly, prevents sudden fat loss, and maintains facial appearance
This resistance is the key to their success, extending their half-life from a couple of minutes to many hours or even a full week, depending on the specific medication
As their use has expanded, questions about cardiovascular safety have become increasingly important for both patients and clinicians
Furthermore, among those already with a SUD, GLP-1s appeared to lower hospitalizations, overdoses, and death, GLP-1 receptor agonists are not replacements for current medication treatments for AUDbut may soon become important additions
While GLP-1 medications can offer significant benefits for weight management and diabetes control, they may not be suitable for everyone